Quality Assurance

 

Albert David Limited (ADL), a prominent drug house, distinguished in the field of manufacturing Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms, Bulk Drugs and Disposable Syringes & Needles has its base in Kolkata, India. The company belongs to a renowned industrial house of Kolkata, the “Kothari Group, India”. Equipped with cutting edge research and development standard and scientific skill, the best brains work here to develop new products for the demanding marketplace worldwide.

Albert David has pioneered the practices of so many modern techniques in many of its research work and implemented innovative ideas. Innovation is a culture here and governs every strategies of the company. We have our state-of-the-art manufacturing facilities in three different parts of the country. The Kolkata manufacturing units is a WHO GMP approved unit and Small Volume Parental suite compliant to USFDA cGMP requirements. Another unit is located at Gaziabad, New Delhi. This unit is ISO 9001:2008 certified plant. The third unit is located at Mandideep, near Bhopal. This unit has the Certificate of Pharmaceutical Products under WHO – GMP Certification Scheme with unique distinction of achieving and acquiring quality accreditation of ISO 9001:2008, ISO 13485:2003 and CE Certification through DNV NORWAY.

Albert David’s core strength lies in its vibrant team of 1500 plus employees and its continuous effort to bring out the best and become the best. The Sales turnover was close to Rs. 320 Crores ( Approximately USD 48 Million ) in the year ended 31st March 2015. With an extensive network of 1600 plus Stockists in various parts of the country, we are able to make our products available in each and every corner of the country. ADL also has significant presence in South East Asia, Africa, countries of Middle–East, Europe, USA and Latin America, covering almost 35 countries.

A pioneer product Sodium stibogluconate which is used to treat leishmaniasis has been manufactured by Albert David Ltd, Calcutta, and is sold under the name Sodium Antimony Gluconate and distributed worldwide through IDA Amesterdam.

Another breakthrough product is ‘Placentrex’ derived from the extract of fresh term healthy human placenta. The Company has come a long way and identified the nucleotides and peptides responsible for anti-inflammatory, wound healing and tissue regenerative property.

The Company is in strategic liaison with academic institutes like Indian Institute of Chemical Biology (CSIR) & Department of Biotechnology, Calcutta University for outsourcing of research.

Objectives

  • To provide the safest formulation in different dosage forms in the market
  • To keep the equipment, the process and the products updated with technological advance corresponding to international quality standards
  • To satisfy our customers within India and abroad with timely delivery and "zero defect" product
  • To ensure cost effective systems in our operations and to achieve quality and productivity
  • To enhance productivity through improved working methods and motivated employees
  • To encourage employee’s involvement at par with the management and to achieve congenial and healthy working atmosphere
  • To provide efficient service to the customers
  • Development for new formulations is carried out by R&D Team

 

R&D activities & Achievements - Albert David Limited (ADL), a prominent drug house, distinguished in the field of manufacturing Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms, Bulk Drugs and Disposable Syringes & Needles has its base in Kolkata, India. The company belongs to a renowned industrial house of Kolkata, the “Kothari Group, India”. Equipped with cutting edge research and development standard and scientific skill, the best brains work here to develop new products for the demanding marketplace worldwide.

Albert David has pioneered the practices of so many modern techniques in many of its research work and implemented innovative ideas. Innovation is a culture here and governs every strategies of the company. We have our state-of-the-art manufacturing facilities in three different parts of the country. The Kolkata manufacturing units is a WHO GMP approved unit and Small Volume Parental suite compliant to USFDA cGMP requirements. Another unit is located at Gaziabad, New Delhi. This unit is ISO 9001:2008 certified plant. The third unit is located at Mandideep, near Bhopal. This unit has the Certificate of Pharmaceutical Products under WHO – GMP Certification Scheme with unique distinction of achieving and acquiring quality accreditation of ISO 9001:2008, ISO 13485:2003 and CE Certification through DNV NORWAY.

Albert David’s core strength lies in its vibrant team of 1500 plus employees and its continuous effort to bring out the best and become the best. The Sales turnover was close to Rs. 320 Crores ( Approximately USD 48 Million ) in the year ended 31st March 2015. With an extensive network of 1600 plus Stockists in various parts of the country, we are able to make our products available in each and every corner of the country. ADL also has significant presence in South East Asia, Africa, countries of Middle–East, Europe, USA and Latin America, covering almost 35 countries.

A pioneer product Sodium stibogluconate which is used to treat leishmaniasis has been manufactured by Albert David Ltd, Calcutta, and is sold under the name Sodium Antimony Gluconate and distributed worldwide through IDA Amesterdam.

Another breakthrough product is ‘Placentrex’ derived from the extract of fresh term healthy human placenta. The Company has come a long way and identified the nucleotides and peptides responsible for anti-inflammatory, wound healing and tissue regenerative property.

The Company is in strategic liaison with academic institutes like Indian Institute of Chemical Biology (CSIR) & Department of Biotechnology, Calcutta University for outsourcing of research.

Assurance

Monitoring of quality standard / good manufacturing practices at each and every stage of manufacturing. We strictly follow the following factors to achieve quality products :
  • Selection and control of drug component – RM/PM
  • For parenteral products quality – special processing of water system is required including dimineralization / multi column distillation to get high quality WFI
  • Manufacturing environment control - giving special classroom facilities to control air borne particulate matter and micro-organizms
  • Proper selection of filtration system - to control liquid borne particulate matter
  • Selection & control of sterilization methods to control viable micro-organisms
  • Selection of proper labelling and packaging to meet drug regulation / market acceptance

 

Most of the findings have been published in journals of national and international repute.
Ongoing Projects of R&D -
 
  • Development of Solid Oral Dosage forms of anti-Leishmaniasis drug Miltefosine to introduce latest line of treatment of Leishmaniasis.
  • Biochemical characterization of the drug Placentrex and identifying it’s active components and their mode of action. Further for label claim of the active components of "Placentrex"
  • Characterization of therapeutic principles of Placentrex to identify the active components and their mechanism of action
  • Development of Solid Oral Dosage form of amino acids and hydroxy-analogue & Keto-analogues of amino acids for treatment of Uremia
  • Development of intravenous injection and solid oral dosage forms of Methylcobalamine
  • For the development of intravenous injection, solid oral dosage form and sustained release solid oral dosage forms of Isoxsuprine
  • Development of Nano particles of FAT Emulsion for Infusion – A TPN Product for Infusion
  • Development of the Product Alamin-RG, an amino acid supplement with arginine
  • Formulation Development of Tamsulosin product and its combination products with dutasteride and finesteride
  • Standardization of amino acids in Placentrex Gel : Development of analytical method for export registration
  • Development of indigenous synthetic route for Miltefosin – an anti-Leishmaniasis Drug, for the development of indigenous capability from API to Product and Import Substitution
  • Development of Sodium Stibo Gluconate in single dosage form (5 ml ampoule) for product extension for exports
  • Various Process and product improvement project plans of existing products for the process and product quality improvements
The direct interaction and such collaboration between Business conglomerates and academics certainly helps to discover new molecules & products for the benefits of the masses, such strong bondages will be definitely mutually beneficial.

Though this is the humble beginning, we are looking forward to much bigger involvements, both financial and academic.
 
Self Inspection & Auditing - Periodically a separate area is audited by the internal audit team with persons responsible for that area. The audit covers the personnel, premises, equipment, procedures and documentation. The findings of the inspection are discussed with the concerned person and the report alongwith recommendations is submitted to the in-charge of the concerned department for necessary action. The result of the periodic and annual inspection is maintained by the quality assurance department.

Fax - +91(033) 2225-8714; 2212-9629
E-Mail - adidavid@dataone.in, adidavid@cal.vsnl.net.in, adlho@adlindia.in